Technology

Alterity Therapeutics

$1.72
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (+3.61%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ATHE and other stocks, options, and ETFs commission-free!

About ATHE

Alterity Therapeutics Ltd. engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. It focuses on Parkinson's movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia. The listed name for ATHE is Alterity Therapeutics Limited American Depositary Shares.

CEO
David A. Stamler
Employees
12
Headquarters
Melbourne, Victoria (VIC)
Founded
1997
Market Cap
63.90M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
504.00K
High Today
$1.76
Low Today
$1.62
Open Price
$1.66
Volume
319.73K
52 Week High
$5.15
52 Week Low
$0.28

Collections

ATHE Earnings

Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 17, Pre-Market

You May Also Like

ANZBY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure